Author(s): Lebrilla CB, An HJ, Lebrilla CB, An HJ
Abstract Share this page
Abstract Over 40 years of literature shows that glycosylation is greatly affected by diseases such as cancer. This opinion article argues the intrinsic advantages of using glycans as disease markers over other biomolecules and the potential of glycan profiling for diagnosing and determining the progression of disease.
This article was published in Mol Biosyst
and referenced in Advanced Techniques in Biology & Medicine